Evidence map›Paper›PMID 31205621›Full record

ArticleInternational journal of hematology-oncology and stem cell research2019

T-Cell B-Rich Lymphoma Presenting as Renal Colic with Positivity of CD3.

Hasan Nabil Al Houri, Tagrid Younes Ahmad, Sarah Zaher Adden, Wisam Hikmat Assad, Ammar Raiy

Open access · diamondAbstract readCase Reports
In one paragraph

Article in International journal of hematology-oncology and stem cell research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hasan Nabil Al HouriDepartment of Internal Medicine, Al Assad University Hospital and Al Mouwasat University Hospital, Damascus, Syria.
Tagrid Younes AhmadDepartment of Internal Medicine, Tishreen Hospital, Damascus, Syria.
Sarah Zaher AddenDepartment of Ophthalmology, Al Mouassat University Hospital, Damascus University, Damascus, Syria.
Wisam Hikmat AssadDepartment of Pathology, Al Mouassat University Hospital and Syrian Private University, Damascus, Syria.
Ammar RaiyDepartment of Kidney Transplant, Al Mouassat University Hospital, Damascus, Syria.
Al Assad University Hospital · SYDamascus University · SYTishreen University · SY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T-Cell Rich B-Cell Lymphoma (TCRBCL) is relatively a new entity, lately classified as a morphologic variant of Diffuse Large B-cell lymphomas (DLBCL). It consists (1-3) % of all B-cell lymphomas. The rate is far less when describing cases of primary splenic involvement with TCRBCL. Pathologically, TCRBCL is described as a limited number of scattered, large, atypical b-cells embedded in a background of abundant t-cells and frequently histiocytes. The similarity of this malignancy with other types makes it difficult to distinguish between them. Thus, it needs expertise in both clinical and pathological fields to make the right diagnosis.Here, we present a case of an adult male patient whose first presentation and previous medical history of renal colic misguided the initial diagnosis and suggested another colic episode as the underlying ailment. However, further physical, radiological and histopathological investigations uncovered the presence of primary TCRBCL within spleen with no involvement of other sites. Moreover, unusual pathologic finding of CD3 positivity was proved by immunohistochemistry.

Indexed as

T-cell-rich B-cell lymphoma; B-cell lymphoma; TCRBCL; Renal colic

Identifiers

PMID31205621
PMCPMC6557966
OpenAlexW2909711046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.